U.S. markets closed

Valneva SE (VALN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
11.58+0.02 (+0.17%)
At close: 02:46PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected


Previous Close11.56
Bid4.70 x 800
Ask11.82 x 1100
Day's Range11.55 - 11.86
52 Week Range9.07 - 17.05
Avg. Volume4,730
Market Cap814.878M
Beta (5Y Monthly)0.93
PE Ratio (TTM)64.33
EPS (TTM)0.18
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est18.64
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
-60% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for VALN

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Valneva SE
    Daily – Vickers Top Buyers & Sellers for 06/29/2023The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Fair Value
    Economic Moat
    3 months agoArgus Research
View more
  • Insider Monkey

    Valneva SE (NASDAQ:VALN) Q2 2023 Earnings Call Transcript

    Valneva SE (NASDAQ:VALN) Q2 2023 Earnings Call Transcript September 21, 2023 Valneva SE misses on earnings expectations. Reported EPS is $0.26 EPS, expectations were $0.36. Operator: Good day, and thank you for standing by. Welcome to the Valneva Half Year 2023 Financial Results Call and Webcast. [Operator Instructions] Please note that today’s conference is being […]

  • GlobeNewswire

    Valneva Announces New IXIARO® Supply Contract with the U.S. Government Worth a Minimum of $32 Million

    Saint Herblain (France), September 25, 2023 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced the signing of a new $32 million contract with the United States (U.S.) Department of Defense (DoD) for the supply of its Japanese encephalitis (JE) vaccine, IXIARO®. Under this new one-year contract, the DoD will buy a minimum of $32 million worth of IXIARO® vaccines and has the possibility to purchase additional doses during the coming twelve months. Delive

  • GlobeNewswire

    Valneva Reports Half Year 2023 Financial Results and Provides Corporate Updates

    Product sales more than doubled in the first half of 2023 to €69.7 million compared to €33.3 million in the first half of 2022 Driven by IXIARO® and DUKORAL® sales, both of which benefited from a continued recovery of the travel industry as well as from price increasesBringing total revenues to €73.7 million in the first half of 2023 Strong cash position of €204.4 million as at June 30, 2023 Excludes up to an additional $100 million made available as part of a recent upsized financing arrangemen